Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 5, 2019 Off

Bicycle Therapeutics to Present New Preclinical Data on BT7480, a Novel, Fully Synthetic Bicycle® Tumor-targeted Immune Cell Agonist, at the Society for Immunotherapy of Cancer’s 2019 Annual Meeting

By BusinessWire

– BT7480 has been selected as the Company’s lead immuno-oncology candidate to advance into IND-enabling studies CAMBRIDGE, England & BOSTON–(BUSINESS…

November 5, 2019 Off

OncoNano Announces Presentations at the 2019 SITC Annual Meeting

By BusinessWire

Two abstracts and posters highlight the diverse applications of OncoNano’s ultra pH-sensitive micelle technology SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc., a…

November 5, 2019 Off

Human Care Systems Releases Version 5.0 of Resilix™ Treatment Experience Platform, Taking Technology for Pharma Patient Services to Next Level of Scalability and Compliance

By BusinessWire

Latest release of pharmaceutical treatment experience platform transitions to scalable microservices approach BOSTON–(BUSINESS WIRE)–Human Care Systems, developer of Resilix™, a…

November 5, 2019 Off

Checkmate Pharmaceuticals Presents Positive Clinical Data with CMP-001 at The 34th Annual Meeting of The Society for Immunotherapy of Cancer (SITC)

By BusinessWire

Objective response rate (ORR) of 25% and duration of response of 16.9+ months observed with CMP-001 in combination with pembrolizumab…

November 5, 2019 Off

Oncternal Therapeutics Announces Interim Clinical Data on TK216 in Ewing Sarcoma to Be Presented at the CTOS 2019 Annual Meeting

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today…

November 5, 2019 Off

Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate

By BusinessWire

-BeiGene and Seattle Genetics to Collaborate on Global Clinical Trials- BOTHELL, Wash. & BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seattle Genetics, Inc.…

November 5, 2019 Off

Experic Welcomes Niyati Patel as the Director of Quality Assurance and Compliance

By BusinessWire

CRANBURY, N.J.–(BUSINESS WIRE)–Experic, a contract manufacturing organization (CMO) and pharmaceutical supply service company, announces the hire of Niyati Patel as…

November 5, 2019 Off

Lineage Cell Therapeutics to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019

By BusinessWire

CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…

November 5, 2019 Off

Frazier Healthcare Partners Adds Experienced Human Capital Professional to Life Sciences Team

By BusinessWire

MENLO PARK, Calif.–(BUSINESS WIRE)–Frazier Healthcare Partners announced Danica Elliott has joined the Frazier Life Sciences team as Director of Human…

November 5, 2019 Off

PureTech Announces Presentation of New Data Supporting Wholly Owned Immuno-Oncology Programs LYT-200 (anti-galectin-9) and LYT-210 (anti-delta-1)

By BusinessWire

Findings further validate targeting galectin-9 as therapeutic approach and biomarker for a number of difficult-to-treat cancers Preclinical data show potency…

Posts pagination

Previous 1 … 5,369 5,370 5,371 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine